GreenLight Biosciences Holdings
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRNA research report →
Companygreenlightbiosciences.com
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
- CEO
- Andrey Juan Zarur
- IPO
- 2022
- Employees
- 280
- HQ
- Medford, MA, US
Price Chart
Valuation
- Market Cap
- $45.43M
- P/E
- -0.24
- P/S
- 7.12
- P/B
- 0.82
- EV/EBITDA
- -0.38
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -2567.65%
- Net Margin
- -2616.78%
- ROE
- -1847.24%
- ROIC
- -126.46%
Growth & Income
- Revenue
- $6.38M · 0.00%
- Net Income
- $-167,055,000 · -45.61%
- EPS
- $-1.27 · -36.56%
- Op Income
- $-163,919,000
- FCF YoY
- -52.62%
Performance & Tape
- 52W High
- $5.90
- 52W Low
- $0.18
- 50D MA
- $0.27
- 200D MA
- $0.85
- Beta
- 1.44
- Avg Volume
- 684.80K
Get TickerSpark's AI analysis on GRNA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 24, 23 | KODIAK VENTURE PARTNERS III LP | other | 9,809,895 |
| May 29, 23 | KODIAK VENTURE PARTNERS III LP | other | 0 |
| Jul 24, 23 | Clarke Dennis A. | other | 25,510.204 |
| Jul 24, 23 | Anderson Eric Senior | other | 25,510.204 |
| Jul 24, 23 | Cummings Foundation, Inc. | other | 1,275,510.204 |
| Jul 24, 23 | COONEY CHARLES L | other | 305,314 |
| Jul 24, 23 | Insud Pharma S.L. | other | 2,551,020 |
| May 29, 23 | MLS Capital Fund II LP | other | 0 |
| Jul 24, 23 | MLS Capital Fund II LP | other | 5,818,575 |
| Jul 24, 23 | PATRICK DEVAL L | other | 172,500 |
Our GRNA Coverage
We haven't published any research on GRNA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GRNA Report →